Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Vaccine production, distribution, access, and uptake.

Smith J, Lipsitch M, Almond JW.

Lancet. 2011 Jul 30;378(9789):428-38. doi: 10.1016/S0140-6736(11)60478-9. Epub 2011 Jun 12.

2.

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Perdue ML, Bright RA.

Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080. Review.

3.

Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group.

Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090. Epub 2015 Jul 3.

4.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.

WHO Writing Group, Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W.

Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8.

5.

Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.

Pagliusi S, Leite LC, Datla M, Makhoana M, Gao Y, Suhardono M, Jadhav S, Harshavardhan GV, Homma A.

Vaccine. 2013 Apr 18;31 Suppl 2:B176-83. doi: 10.1016/j.vaccine.2012.11.060. Review.

PMID:
23598479
6.

The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.

Jadhav S, Datla M, Kreeftenberg H, Hendriks J.

Vaccine. 2008 Mar 20;26(13):1611-5. doi: 10.1016/j.vaccine.2008.01.034. Epub 2008 Feb 6. Review.

PMID:
18294742
7.
8.

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.

Friede M, Palkonyay L, Alfonso C, Pervikov Y, Torelli G, Wood D, Kieny MP.

Vaccine. 2011 Jul 1;29 Suppl 1:A2-7. doi: 10.1016/j.vaccine.2011.02.079. Review.

9.
10.

Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges.

Hessel L; European Vaccine Manufacturers (EVM) Influenza Working Group.

Influenza Other Respir Viruses. 2009 Jul;3(4):165-70. doi: 10.1111/j.1750-2659.2009.00085.x. Review.

11.

Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.

Pagliusi S, Makhoana M, Datla M, Leite L, Hendriks J, Gholami A, Huang W, Gao Y, Jadhav S, Harshavardhan GV, Wu Y, Suhardono M, Homma A.

Vaccine. 2013 Jun 28;31(31):3111-5. doi: 10.1016/j.vaccine.2013.04.082. Epub 2013 May 15.

PMID:
23684836
12.

Strengthening vaccination policies in Latin America: an evidence-based approach.

Tapia-Conyer R, Betancourt-Cravioto M, Saucedo-Martínez R, Motta-Murguía L, Gallardo-Rincón H.

Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25. Review.

PMID:
23357196
13.
14.

Vaccine manufacturing: challenges and solutions.

Ulmer JB, Valley U, Rappuoli R.

Nat Biotechnol. 2006 Nov;24(11):1377-83.

PMID:
17093488
15.

Availability of quality vaccines: the industrial point of view.

Vandersmissen W.

Vaccine. 1992;10(13):955-7.

PMID:
1471420
16.

Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).

Palache A, Oriol-Mathieu V, Abelin A, Music T; Influenza Vaccine Supply task force (IFPMA IVS).

Vaccine. 2014 Nov 12;32(48):6369-76. doi: 10.1016/j.vaccine.2014.07.012. Epub 2014 Nov 1. Review.

17.

Vaccine supply, demand, and policy: a primer.

Muzumdar JM, Cline RR.

J Am Pharm Assoc (2003). 2009 Jul-Aug;49(4):e87-99. doi: 10.1331/JAPhA.2009.09007. Review.

PMID:
19589753
18.

The role of emerging manufacturers in access to innovative vaccines of public health importance.

Milstien JB, Kaddar M.

Vaccine. 2010 Feb 25;28(9):2115-21. doi: 10.1016/j.vaccine.2009.12.036. Epub 2009 Dec 29.

PMID:
20044054
19.
20.

An international technology platform for influenza vaccines.

Hendriks J, Holleman M, de Boer O, de Jong P, Luytjes W.

Vaccine. 2011 Jul 1;29 Suppl 1:A8-11. doi: 10.1016/j.vaccine.2011.04.124. Review.

Supplemental Content

Support Center